We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.79B
AUM Growth
+$493M
Cap. Flow
+$186M
Cap. Flow %
3.21%
Top 10 Hldgs %
23.53%
Holding
286
New
43
Increased
91
Reduced
94
Closed
31

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$52.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$43.8M
3
ABT icon
Abbott
ABT
+$37.3M
4
AMGN icon
Amgen
AMGN
+$35M
5
AME icon
Ametek
AME
+$28.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.2M
2
N
Netsuite Inc
N
+$40M
3
AGN
Allergan plc
AGN
+$39.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$38.9M
5
BCR
CR Bard Inc.
BCR
+$33.3M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Healthcare 21.19%
3 Financials 20.46%
4 Communication Services 9.97%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZD icon
176
Ziff Davis
ZD
$1.9B
$4.71M 0.08%
81,390
+4,485
+6% +$261K
SIVB
177
DELISTED
SVB Financial Group
SIVB
$4.25M 0.07%
38,445
+11,253
+41% +$1.17M
NVDQ
178
DELISTED
Novadaq Technologies Inc.
NVDQ
$4.21M 0.07%
364,611
+189,611
+108% +$2.06M
PCTY icon
179
Paylocity
PCTY
$6.71B
$4.1M 0.07%
+92,254
New +$4.09M
PPBI
180
DELISTED
Pacific Premier Bancorp
PPBI
$3.89M 0.07%
147,052
-82,544
-36% -$2.13M
MAIN icon
181
Main Street Capital
MAIN
$4.97B
$3.87M 0.07%
112,500
– –
DOC icon
182
Healthpeak Properties
DOC
$15.4B
$3.79M 0.07%
109,800
– –
ICPT
183
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.79M 0.07%
23,000
+1,131
+5% +$178K
N
184
DELISTED
Netsuite Inc
N
$3.59M 0.06%
32,424
-396,839
-92% -$40M
BOX icon
185
Box
BOX
$4.02B
$3.55M 0.06%
225,633
-380,112
-63% -$4.81M
MB
186
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$3.35M 0.06%
+170,795
New +$2.99M
PPLI
187
People Inc
PPLI
$3.1B
$3.35M 0.06%
299,455
– –
OAK
188
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$3.28M 0.06%
77,500
– –
MPT
189
Medical Properties Trust
MPT
$2.89B
$2.95M 0.05%
200,000
– –
MIXT
190
DELISTED
MIX TELEMATICS LIMITED
MIXT
$2.8M 0.05%
+440,874
New +$2.36M
CASH icon
191
Pathward Financial
CASH
$1.81B
$2.76M 0.05%
136,626
+101,307
+287% +$1.93M
ALXN
192
DELISTED
Alexion Pharmaceuticals
ALXN
$2.6M 0.05%
21,250
+11,730
+123% +$1.51M
EWBC icon
193
East-West Bancorp
EWBC
$17.9B
$2.57M 0.04%
70,000
+20,000
+40% +$704K
NXTM
194
DELISTED
NxStage Medical Inc.
NXTM
$2.5M 0.04%
100,000
-275,194
-73% -$6.42M
ALDR
195
DELISTED
Alder Biopharmaceuticals
ALDR
$2.46M 0.04%
75,000
– –
MCO icon
196
Moody's
MCO
$81.7B
$2.35M 0.04%
21,718
-2,560
-11% -$269K
DHC
197
Diversified Healthcare Trust
DHC
$2.26B
$2.27M 0.04%
100,000
– –
PRLB icon
198
Protolabs
PRLB
$1.86B
$2.26M 0.04%
+37,774
New +$2.17M
RDUS
199
DELISTED
Radius Health, Inc.
RDUS
$2.25M 0.04%
41,500
-11,081
-21% -$563K
CSLT
200
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2.16M 0.04%
519,704
+100,000
+24% +$408K
6 7
8
9 10

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Polar Capital held 286 positions worth $5.79B, up 9.3% from $5.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $186M of net new capital in Q3 2016, opening 43 new positions and adding to 91 existing holdings. Its largest new stake was Canadian Natural Resources: 2,876,960 shares worth $52.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $66.2M trimmed.

  • Polar Capital's largest Q3 2016 buy was Canadian Natural Resources: 2,876,960 shares worth $52.7M.
  • Polar Capital added most to Merck in Q3 2016, an estimated $52.9M increase.
  • Polar Capital's biggest Q3 2016 reduction was Pfizer, cutting an estimated $66.2M.
  • Polar Capital fully exited Allergan plc in Q3 2016, selling an estimated $39.6M.
  • Polar Capital's ten largest holdings make up 24% of its $5.79B portfolio in Q3 2016.
  • Polar Capital opened 43 new positions and closed 31 in Q3 2016.
  • Polar Capital's portfolio value rose 9.3% quarter-over-quarter to $5.79B.

Based on Polar Capital's 13F filing for Q3 2016, filed 14 Nov 2016.